SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine.

Whitaker, HC; Kote-Jarai, Z; Ross-Adams, H; Warren, AY; Burge, J; George, A; Bancroft, E; Jhavar, S; Leongamornlert, D; Tymrakiewicz, M; et al. Whitaker, HC; Kote-Jarai, Z; Ross-Adams, H; Warren, AY; Burge, J; George, A; Bancroft, E; Jhavar, S; Leongamornlert, D; Tymrakiewicz, M; Saunders, E; Page, E; Mitra, A; Mitchell, G; Lindeman, GJ; Evans, DG; Blanco, I; Mercer, C; Rubinstein, WS; Clowes, V; Douglas, F; Hodgson, S; Walker, L; Donaldson, A; Izatt, L; Dorkins, H; Male, A; Tucker, K; Stapleton, A; Lam, J; Kirk, J; Lilja, H; Easton, D; IMPACT Study Steering Committee; IMPACT Study Collaborators; UK GPCS Collaborators; Cooper, C; Eeles, R; Neal, DE (2010) The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine. PLOS ONE, 5 (10). e13363. ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0013363
SGUL Authors: Hodgson, Shirley Victoria

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (2MB) | Preview

Abstract

BACKGROUND: Microseminoprotein-beta (MSMB) regulates apoptosis and using genome-wide association studies the rs10993994 single nucleotide polymorphism in the MSMB promoter has been linked to an increased risk of developing prostate cancer. The promoter location of the risk allele, and its ability to reduce promoter activity, suggested that the rs10993994 risk allele could result in lowered MSMB in benign tissue leading to increased prostate cancer risk. METHODOLOGY/PRINCIPAL FINDINGS: MSMB expression in benign and malignant prostate tissue was examined using immunohistochemistry and compared with the rs10993994 genotype. Urinary MSMB concentrations were determined by ELISA and correlated with urinary PSA, the presence or absence of cancer, rs10993994 genotype and age of onset. MSMB levels in prostate tissue and urine were greatly reduced with tumourigenesis. Urinary MSMB was better than urinary PSA at differentiating men with prostate cancer at all Gleason grades. The high risk allele was associated with heterogeneity of MSMB staining and loss of MSMB in both tissue and urine in benign prostate. CONCLUSIONS: These data show that some high risk alleles discovered using genome-wide association studies produce phenotypic effects with potential clinical utility. We provide the first link between a low penetrance polymorphism for prostate cancer and a potential test in human tissue and bodily fluids. There is potential to develop tissue and urinary MSMB for a biomarker of prostate cancer risk, diagnosis and disease monitoring.

Item Type: Article
Additional Information: ©2010 Whitaker et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Alleles, Enzyme-Linked Immunosorbent Assay, Genetic Predisposition to Disease, Genotype, Humans, Immunohistochemistry, Male, Prostate-Specific Antigen, Prostatic Neoplasms, Prostatic Secretory Proteins, Tumor Markers, Biological, Science & Technology, Multidisciplinary Sciences, Science & Technology - Other Topics, 94 AMINO-ACIDS, SECRETORY PROTEIN, PSP94 EXPRESSION, RADICAL PROSTATECTOMY, MESSENGER-RNA, MODEL, SUSCEPTIBILITY, ANGIOGENESIS, ASSOCIATION, PROGRESSION
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Cell Sciences (INCCCS)
Journal or Publication Title: PLOS ONE
ISSN: 1932-6203
Related URLs:
Dates:
DateEvent
13 October 2010Published
Web of Science ID: WOS:000282869800041
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/953
Publisher's version: https://doi.org/10.1371/journal.pone.0013363

Actions (login required)

Edit Item Edit Item